NO912943L - Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser. - Google Patents

Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser.

Info

Publication number
NO912943L
NO912943L NO91912943A NO912943A NO912943L NO 912943 L NO912943 L NO 912943L NO 91912943 A NO91912943 A NO 91912943A NO 912943 A NO912943 A NO 912943A NO 912943 L NO912943 L NO 912943L
Authority
NO
Norway
Prior art keywords
pct
treatment
demylination
disorders
long
Prior art date
Application number
NO91912943A
Other languages
English (en)
Other versions
NO912943D0 (no
Inventor
Keith Coupland
Nigel Alan Langley
Original Assignee
Croda Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898927109A external-priority patent/GB8927109D0/en
Priority claimed from GB909016660A external-priority patent/GB9016660D0/en
Application filed by Croda Int Plc filed Critical Croda Int Plc
Publication of NO912943D0 publication Critical patent/NO912943D0/no
Publication of NO912943L publication Critical patent/NO912943L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO91912943A 1989-11-30 1991-07-29 Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser. NO912943L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898927109A GB8927109D0 (en) 1989-11-30 1989-11-30 Pharmaceutical compositions
GB909016660A GB9016660D0 (en) 1990-07-30 1990-07-30 Pharmaceutical compositions
PCT/GB1990/001870 WO1991007955A1 (en) 1989-11-30 1990-11-30 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders

Publications (2)

Publication Number Publication Date
NO912943D0 NO912943D0 (no) 1991-07-29
NO912943L true NO912943L (no) 1991-07-29

Family

ID=26296282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912943A NO912943L (no) 1989-11-30 1991-07-29 Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser.

Country Status (10)

Country Link
US (1) US5194448A (no)
EP (1) EP0455783B1 (no)
JP (1) JPH07500566A (no)
AT (1) ATE135208T1 (no)
DE (1) DE69025922T2 (no)
DK (1) DK0455783T3 (no)
ES (1) ES2087165T3 (no)
GR (1) GR3019315T3 (no)
NO (1) NO912943L (no)
WO (1) WO1991007955A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
GB9418420D0 (en) * 1994-09-13 1994-11-02 Mckeown Neil A Composition for the treatment of an energy imbalance in ruminents
IL119661A0 (en) * 1996-11-20 1997-02-18 Yehuda Shlomo Medical use of composition comprising fatty acids
DE19711777A1 (de) * 1997-03-21 1998-09-24 K D Pharma Gmbh Bestandteil eines Hautpflegemittels
US6652866B1 (en) * 1997-10-14 2003-11-25 David W. Hertha Method for treating diseases of fungal, yeast, and prion protein etiology
US6126986A (en) * 1999-02-23 2000-10-03 Westway Trading Corporation Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid
GB9927629D0 (en) * 1999-11-24 2000-01-19 Croda Int Plc Compounds
GB0112324D0 (en) * 2001-05-21 2001-07-11 Croda Int Plc Compounds
DE10148065A1 (de) * 2001-09-28 2003-04-17 Max Planck Gesellschaft (Ester)-Lysolecithine in Liposomen
US6949586B2 (en) * 2002-02-11 2005-09-27 Council Of Scientific Research Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity
GB0604647D0 (en) 2006-03-08 2006-04-19 Shchepinov Mikhail Stabilized food supplements and their derivatives
EP2339346B1 (en) * 2006-03-24 2014-09-03 Metanomics GmbH Methods for predicting diabetes type II
CA2670018C (en) 2006-11-21 2018-12-11 National Research Council Of Canada Cardamine graeca fae genes and their use in producing nervonic and eicosenoic acids in seed oils
CA2777827C (en) 2009-10-30 2020-08-18 Retrotope, Inc. Alleviating oxidative stress disorders with pufa derivatives
AU2012249917B2 (en) 2011-04-26 2017-06-15 Biojiva Llc Neurodegenerative disorders and muscle diseases implicating PUFAs
EP3689342A1 (en) 2011-04-26 2020-08-05 Retrotope, Inc. Oxidative retinal diseases
AU2012249920B2 (en) 2011-04-26 2017-06-15 Biojiva Llc Disorders implicating PUFA oxidation
AU2012249918B2 (en) 2011-04-26 2017-06-15 Biojiva Llc Impaired energy processing disorders and mitochondrial deficiency
EP2780316B1 (en) * 2011-11-13 2020-04-15 Blanchette Rockefeller Neurosciences Institute Esters of dcpla and methods of treatment using the same
CA3005983A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
CN105853996A (zh) * 2016-03-31 2016-08-17 山东健科生物技术有限公司 一种脑神经激活修复液
CN107441130A (zh) * 2017-08-04 2017-12-08 杨宇明 一种含蒜头果有效提取物的抗阿尔茨海默病的组合物及其应用
NO20181574A1 (en) * 2018-12-06 2020-06-08 Epax Norway As Very long chain fatty acids
AU2020283321B2 (en) * 2019-05-31 2025-04-24 Epax Norway As Very long chain fatty acids for treatment and alleviation of diseases
US20220347144A1 (en) * 2019-09-27 2022-11-03 University Of Virginia Patent Foundation Compositions and methods for preventing and/or reducing weight gain and associated conditions
CA3172351A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
CN111735888B (zh) * 2020-08-14 2020-11-20 宝枫生物科技（北京）有限公司 用于诊断元宝枫籽油中神经酸起效的生物标记物及其应用
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3261761D1 (en) * 1981-07-14 1985-02-14 Efamol Ltd Pharmaceutical and dietary composition when used for enhancement of 1-series pg production
US4505933A (en) * 1982-02-01 1985-03-19 Hoerrmann Wilhelm Fatty aldehydes in the treatment of Multiple Sclerosis
CH679119A5 (no) * 1988-05-13 1991-12-31 Sandoz Ag

Also Published As

Publication number Publication date
NO912943D0 (no) 1991-07-29
ES2087165T3 (es) 1996-07-16
JPH07500566A (ja) 1995-01-19
ATE135208T1 (de) 1996-03-15
DE69025922T2 (de) 1996-10-02
WO1991007955A1 (en) 1991-06-13
GR3019315T3 (en) 1996-06-30
EP0455783B1 (en) 1996-03-13
US5194448A (en) 1993-03-16
EP0455783A1 (en) 1991-11-13
DK0455783T3 (da) 1996-04-01
DE69025922D1 (de) 1996-04-18

Similar Documents

Publication Publication Date Title
NO912943L (no) Anvendelse av nervonsyre og langkjedete fettsyrer for behandling av demyelineringsforstyrrelser.
DK0539448T3 (da) Levnedsmiddelsammensætninger og farmaceutiske sammensætninger indeholdende kortkædede, monoumættede fedtsyrer og fremgangsmåde til anvendelse
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
ATE43242T1 (de) Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
DE3486235D1 (de) Fettsäure-Zusammensetzungen.
ATE8790T1 (de) Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
DE69005950D1 (de) Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE245427T1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
ATE258792T1 (de) Diät mit hohem lipidgehalt
CH678918A5 (no)
GB2201685B (en) Composition for occlusion of ducts and cavities of human body
SE8800989D0 (sv) Dietary composition and process for preparing same
MX169500B (es) Producion de sabor
DE3878812D1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
NO170011C (no) Analogifremgangsmaate til fremstilling av propanolaminderivater
NO894083L (no) Farmasoeytiske blandinger for behandling av adrenoleukodystrophy.
DE69008762D1 (de) Retinsäureester von l-Cladinos, Verfahren zu deren Herstellung und ihre Verwendung in der Human- oder Veterinärmedizin und in der Kosmetik.
DE69326075D1 (de) Verwendung von Zusammensetzungen essentieller Fettsäuren
ATE197764T1 (de) Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.
DE69109293D1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
NO178457C (no) Fremgangsmåte for fremstilling av et salisylsyreholdig preparat for behandling av hudsykdommer med avskalling
BG49398A1 (en) Means for inrooting of the actinades